Clinical trial

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

NCT00343382 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00343382
Title Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
Official title Pilocarpine for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Breast Cancer, Vaginal Dryness
Intervention type Drug, Other
Interventions pilocarpine hydrochloride, placebo
Enrollment 201
Start date Dec 1, 2006
Primary completion Jul 1, 2009
Completion Dec 1, 2012
First posted Jun 23, 2006
Last update posted Aug 12, 2016
Countries United States

At a glance

  • 100–999 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies